Fesoterodine

FDA Drug Profile

Drug Details

Generic Name
Fesoterodine
Brand Names
N/A
Application Number
Sponsor
MSN Pharmachem Private Limited
NDC Codes
2
Dosage Forms
POWDER
Routes
N/A
Active Ingredients
FESOTERODINE, FESOTERODINE FUMARATE

Indications and Usage

1 INDICATIONS AND USAGE Fesoterodine fumarate extended-release tablets are indicated for the treatment of: Overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency. ( 1.1 ) 1.1 Adult Overactive Bladder Fesoterodine fumarate extended-release tablets are indicated for the treatment of overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency. Pediatric use information is approved for Pfizer Inc.'s TOVIAZ ® (fesoterodine fumarate) Extended-Release Tablets. However, due to Pfizer Inc.'s marketing exclusivity rights, this drug product is not labeled with that pediatric information.